Cells Built for Discovery
abm's stem cell-derived cell lines deliver the functional phenotype, genetic consistency, and lot-to-lot reproducibility your research depends on — from disease modelling to high-throughput drug screening.
Select the organ system most relevant to your research
abm's stem cell-derived portfolio is organised by organ system so researchers can explore available cell types, validated protocols, and supporting reagents.
Neurological System
Human and rodent neuronal and glial models for CNS disease research, neuropharmacology, and electrophysiology.
Explore neurological system cells →
Cardiovascular System
Beating human cardiomyocytes derived from ESCs deliver physiologically relevant models for cardiotoxicity assessment and disease modelling.
Explore cardiovascular system cells →Research-ready models for discovery workflows
Stem cell-derived cells support a broad range of research applications, from disease modelling to screening and downstream assay development.
Specialised cell models generated through directed differentiation
Stem cell-derived cells are terminally differentiated, lineage-committed cell types generated from pluripotent or multipotent precursors using stage-directed differentiation protocols.
Induced Pluripotent Stem Cell-Derived
Adult somatic cells are reprogrammed to pluripotency and then re-differentiated into the target cell type through lineage-specific protocols.
- Retains the donor's genetic identity
- Supports patient-specific disease modelling
- Enables isogenic experimental designs
Embryonic Stem Cell-Derived
ESCs provide a well-characterised pluripotent source with defined transcriptomic, epigenomic, and karyotypic profiles.
- No somatic epigenetic memory
- No reprogramming-associated variation
- Useful when baseline gene expression and reproducibility matter
Tissue Progenitor-Derived
Multipotent progenitors sit downstream of pluripotency, bypassing the pluripotent intermediate entirely.
- Reduces differentiation heterogeneity
- Shortens protocol timelines
- Better preserves tissue-specific epigenetic signatures
A defined path from precursor to application-ready model
Directed differentiation uses defined combinations of morphogens, growth factors, and small molecules to guide pluripotent precursors through stage-specific intermediates into mature, functional cell types.
What makes stem cells useful as a starting material?
Stem cells are rare, undifferentiated progenitor cells defined by self-renewal and potency. Together, these properties make them a foundational substrate for generating unlimited, genetically defined human cell populations.
Self-Renewal
Stem cells maintain an undifferentiated state across successive divisions through tightly regulated transcriptional networks.
Potency
Their differentiation repertoire depends on developmental origin and epigenetic state, from totipotent cells to tissue-committed progenitors.
Reprogramming & Plasticity
Somatic cells can be reverted to pluripotency using defined transcription factors, enabling iPSC-derived, donor-specific cell types.
Stem cell classification by potency
Totipotent
Competent to generate embryonic and extraembryonic lineages, including trophectoderm and primitive endoderm. Confined to the zygote and early blastomeres.
Pluripotent
Can differentiate into any cell type of the three germ layers. Includes embryonic stem cells and induced pluripotent stem cells.
Multipotent
Restricted to generating cell types within a specific lineage, such as hematopoietic stem cells or neural stem cells.
Unipotent
Committed to producing a single mature cell type, such as muscle satellite cells or some epithelial progenitors.
Built on rigorous science, delivered with workflow-level support
abm stem cell-derived cell lines are designed for consistency, biological relevance, and practical support from thaw to downstream assay.
Defined & Reproducible
Standardised, chemically defined differentiation protocols with fixed release criteria support consistent performance lot-to-lot, experiment-to-experiment, and lab-to-lab.
Biology, Without the Trade-Offs
iPSC- and ESC-derived cell lines provide genetic context that transformed lines cannot offer, at a scale and consistency primary cells cannot sustain.
Complete Cell Biology Ecosystem
Matched media, coating solutions, and 3D culture matrices are developed and validated alongside abm's stem cell-derived cells.
Expert Support, Not Just a Catalogue
abm's cell biology scientists provide protocol guidance, troubleshooting, and application support when establishing or scaling a workflow.
Compare primary cells, immortalised lines, and stem cell-derived models
Not all in vitro cell models are created equal. Understanding the trade-offs helps you match the model to your research question.
| Criterion | Primary Cells | Immortalised Lines | Stem Cell-Derived (abm) |
|---|---|---|---|
| Human Relevance | ✓ High — tissue-native | ∼ Variable — often transformed | ✓ High — human iPSC/ESC origin |
| Lot-to-Lot Consistency | ✗ Low — donor-dependent | ✓ High | ✓ High — defined protocols |
| Scalability | ✗ Limited by donor supply | ✓ Unlimited | ✓ Scalable, renewable source |
| Genetic Fidelity | ✓ Native genome preserved | ✗ Often mutated or transformed | ✓ Donor genetics retained (iPSC) |
| Patient-Specific Modelling | ∼ Possible but difficult | ✗ Not applicable | ✓ Native via iPSC reprogramming |
| Functional Maturity | ✓ Mature, tissue-native | ✗ Often de-differentiated | ✓ Functionally validated |
| 3D / Organoid Compatible | ∼ Case-dependent | ∼ Limited | ✓ Compatible with 3D systems |
| Lifespan in Culture | ✗ Short — limited passages | ✓ Indefinite | ∼ Defined culture window |
| Regulatory Acceptance | ∼ Accepted, variable | ✗ Not preferred for safety studies | ✓ CiPA / FDA-aligned (cardiomyocytes) |
Everything you need to get from thaw to data
Access protocols, documentation, and direct support from abm's cell biology team.
Certificate of Analysis Library
Access lot-specific CoAs for all abm cell lines, including identity markers, viability data, mycoplasma status, and functional validation results.
Search CoA library →Learning Resources
Browse protocols, application notes, and guides covering cell culture best practices, differentiation workflows, and downstream assay setup.
Browse learning resources →Technical Support
Connect with abm's cell biology team for troubleshooting, protocol optimisation, and guidance on cell type and culture conditions.
Contact technical support →Frequently asked questions
Common questions about stem cells, stem cell-derived cell lines, and selecting the right model for your research.
What is the difference between a stem cell and a stem cell-derived cell?
Are abm's stem cell-derived cells human or animal origin?
How do stem cell-derived cells compare to primary cells?
Can stem cell-derived cells be used in 3D culture and organoid models?
What quality controls are applied to abm's stem cell-derived cells?
What media and reagents does abm recommend for culturing these cells?
Ready to elevate your cell models?
Request a quote or speak to one of abm's cell biology specialists.